β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes
Author(s) -
E. Philip Horwitz,
Lars Krogvold,
Sophia Zhitomirsky,
Avital Swisa,
Maya Fischman,
Tsuria Lax,
Tehila Dahan,
Noa Hurvitz,
Noa Weinberg-Corem,
Agnes Klochendler,
Alvin C. Powers,
Marcela Briššová,
Anne Jörns,
Sigurd Lenzen,
Benjamin Gläser,
Knut DahlJørgensen,
Yuval Dor
Publication year - 2018
Publication title -
diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.219
H-Index - 330
eISSN - 1939-327X
pISSN - 0012-1797
DOI - 10.2337/db17-1006
Subject(s) - proinflammatory cytokine , insulitis , islet , inflammation , streptozotocin , autoimmunity , immune system , biology , immunology , cell , medicine , endocrinology , diabetes mellitus , genetics
Type 1 diabetes (T1D) is an autoimmune disease where pancreatic β-cells are destroyed by islet-infiltrating T cells. Although a role for β-cell defects has been suspected, β-cell abnormalities are difficult to demonstrate. We show a β-cell DNA damage response (DDR), presented by activation of the 53BP1 protein and accumulation of p53, in biopsy and autopsy material from patients with recently diagnosed T1D as well as a rat model of human T1D. The β-cell DDR is more frequent in islets infiltrated by CD45+ immune cells, suggesting a link to islet inflammation. The β-cell toxin streptozotocin (STZ) elicits DDR in islets, both in vivo and ex vivo, and causes elevation of the proinflammatory molecules IL-1β and Cxcl10. β-Cell–specific inactivation of the master DNA repair gene ataxia telangiectasia mutated (ATM) in STZ-treated mice decreases the expression of proinflammatory cytokines in islets and attenuates the development of hyperglycemia. Together, these data suggest that β-cell DDR is an early event in T1D, possibly contributing to autoimmunity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom